Nurix Therapeutics Announces Regulatory Clearance to
U.K. regulatory authorities grant Clinical Trial Authorization with dosing of first patient anticipated in the first half of 2022 NXā5948 crosses the...
United States United Kingdom San Francisco Robertj Brown Danielw Robbins American Society Of Hematology
Source: globenewswire.com